Related Experiment Video
Updated: May 5, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice
Abstract:
Smooth muscle cell (SMC) accumulation is a key event in the development of atherosclerosis, including vein bypass graft arteriosclerosis. Because members of the protein kinase C (PKC) family signal cells to undergo proliferation, differentiation, or apoptosis, we generated PKCdelta knockout mice and performed vein bypass grafts on these animals. PKCdelta(-/-) mice developed normally and were fertile. Vein segments from PKCdelta(-/-) mice isografted to carotid arteries of recipient mice of either genotype led to a more severe arteriosclerosis than was seen with PKCdelta(+/+) vein grafts. Arteriosclerotic lesions in PKCdelta(-/-) mice showed a significantly higher number of SMCs than were found in wild-type animals; this was correlated with decreased SMC death in lesions of PKCdelta(-/-) mice. SMCs derived from PKCdelta(-/-) aortae were resistant to cell death induced by any of several stimuli, but they were similar to wild-type SMCs with respect to mitogen-stimulated cell proliferation in vitro. Furthermore, pro-apoptotic treatments led to diminished caspase-3 activation, poly(ADP-ribose) polymerase cleavage, and cytochrome c release in PKCdelta(-/-) relative to wild-type SMCs, suggesting that their apoptotic resistance involves the loss of free radical generation and mitochondrial dysfunction in response to stress stimuli. Our data indicate that PKCdelta maintains SMC homeostasis and that its function in the vessel wall per se is crucial in the development of vein graft arteriosclerosis.
Insights
Protein kinase C delta (PKCdelta) deficiency in smooth muscle cells (SMCs) worsens vein graft arteriosclerosis by reducing SMC death. PKCdelta is crucial for maintaining SMC homeostasis and normal vascular function.
Area of Science:
- Vascular Biology
- Cellular Signaling
- Atherosclerosis Research
Background:
- Smooth muscle cell (SMC) accumulation drives atherosclerosis, including vein bypass graft disease.
- Protein kinase C (PKC) signaling pathways regulate SMC fate (proliferation, differentiation, apoptosis).
Purpose of the Study:
- To investigate the role of PKCdelta in SMC behavior and vein graft arteriosclerosis development.
Main Methods:
- Generated and utilized PKCdelta knockout (PKCdelta(-/-)) mice for vein bypass grafting experiments.
- Compared arteriosclerosis severity, SMC accumulation, and SMC apoptosis in PKCdelta(-/-) and wild-type (PKCdelta(+/+)) grafts.
- Assessed SMC resistance to apoptosis and related molecular pathways (caspase-3, PARP, cytochrome c) in vitro.
Main Results:
- PKCdelta(-/-) vein grafts exhibited more severe arteriosclerosis with increased SMCs and decreased SMC death compared to wild-type grafts.
- SMCs from PKCdelta(-/-) mice showed resistance to apoptosis induction, characterized by diminished caspase-3 activation and mitochondrial dysfunction.
- PKCdelta deficiency did not affect SMC proliferation in vitro.
Conclusions:
- PKCdelta plays a critical role in maintaining SMC homeostasis within the vessel wall.
- Loss of PKCdelta function exacerbates vein graft arteriosclerosis by promoting SMC survival and impairing apoptotic responses.

